Skip to main content
    C

    Context Therapeutics Inc (CNTX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.17
    -0.01 (-8.24%)

    Market Cap: $16.61M

    Last updated: Nov 17, 2026 at 11:04 AM ET

    Context Therapeutics Inc (CNTX) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Context Therapeutics are Transcode Therapeutics (RNAZ), Cyclerion Therapeutics (CYCN) and Plus Therapeutics (PSTV). By market cap, Context Therapeutics ranks 7th of the 13 companies on this page; Quince Therapeutics (QNCX) is the largest at $32.27M.

    Peer Comparison

    CNTX's revenue growth of 0.0% is above the peer median of -1.4%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Context Therapeutics (CNTX)$16.61MN/AN/A0.0%N/A0.0%0.00%
    Transcode Therapeutics Inc (RNAZ)$22.35MN/AN/A0.0%-412.7%0.0%0.00%
    Cyclerion Therapeutics Inc (CYCN)$15.73MN/AN/A0.0%N/A-43.2%0.00%
    Plus Therapeutics Inc (PSTV)$26.64MN/A2.0x-230.2%-827.8%-2.9%0.00%
    Tscan Therapeutics Inc (TCRX)$10.89MN/A3.6x0.0%-129.7%-65.8%0.00%
    Citius Pharmaceuticals Inc (CTXR)$14.69MN/A1.9x0.0%-84.3%0.0%0.00%
    Quoin Pharmaceuticals Ltd DRC (QNRX)$17.78MN/AN/A0.0%N/A0.0%0.00%
    NextCure Inc (NXTC)$29.31MN/AN/A0.0%N/A-100.0%0.00%
    Marker Therapeutics Inc (MRKR)$14.51MN/A14.5x-245.5%N/A-51.0%0.00%
    Cocrystal Pharma Inc (COCP)$18.88MN/A39.2x0.0%N/A26.9%0.00%
    Akari Therapeutics PLC (AKTX)$15.54MN/AN/A0.0%N/A0.0%0.00%
    Fractyl Health, Inc. Common Stock (GUTS)$11.99MN/AN/A0.0%-245.8%-57.1%0.00%
    Quince Therapeutics, Inc. (QNCX)$32.27MN/AN/A0.0%N/A0.0%0.00%
    Peer median$16.75MN/A3.6x0.0%-245.8%-1.4%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Context Therapeutics, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Transcode Therapeutics Inc (RNAZ)
    TransCode Therapeutics, Inc., a biopharmaceutical company, is dedicated to the development and commercialization of drugs for the treatment of metastatic...
    RNAZ competitors
    Cyclerion Therapeutics Inc (CYCN)
    Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to the discovery, development...
    Plus Therapeutics Inc (PSTV)
    Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacturing...
    PSTV competitors
    Tscan Therapeutics Inc (TCRX)
    Tscan Therapeutics Inc (TCRX) is a pioneering clinical-stage biotechnology company specializing in precision oncology through its proprietary T cell receptor...
    TCRX competitors
    Citius Pharmaceuticals Inc (CTXR)
    Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and markets critical care products.
    CTXR competitors
    Quoin Pharmaceuticals Ltd DRC (QNRX)
    Quoin Pharmaceuticals Ltd (QNRX) is an innovative biotechnology firm dedicated to developing cutting-edge therapeutics for rare diseases...
    QNRX competitors
    NextCure Inc (NXTC)
    NextCure, Inc., a clinical-stage biopharmaceutical company, is dedicated to the discovery and development of novel immunomedicines to treat cancer and other...
    NXTC competitors
    Marker Therapeutics Inc (MRKR)
    Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, is dedicated to the development and commercialization of various T-cell-based...
    MRKR competitors
    Cocrystal Pharma Inc (COCP)
    Cocrystal Pharma, Inc., a biotechnology company, is focused on the discovery and development of antiviral therapeutic treatments for serious and / or chronic...
    COCP competitors
    Akari Therapeutics PLC (AKTX)
    Akari Therapeutics, Plc, a clinical-stage biopharmaceutical company, focuses on the development and commercialization of treatments for autoinflammatory...
    AKTX competitors
    Fractyl Health, Inc. Common Stock (GUTS)
    Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity.
    GUTS competitors
    Quince Therapeutics, Inc. (QNCX)
    Quince Therapeutics, Inc., a biopharmaceutical company, is focused on advancing precision therapies for rare and debilitating diseases.

    Frequently Asked Questions About CNTX

    Who are Context Therapeutics' main competitors?

    The companies most similar to Context Therapeutics include Transcode Therapeutics (RNAZ), Cyclerion Therapeutics (CYCN), Plus Therapeutics (PSTV), Tscan Therapeutics (TCRX) and Citius Pharmaceuticals (CTXR), listed from the closest match.

    Who is Context Therapeutics' biggest competitor?

    Quince Therapeutics (QNCX) is the largest of the similar companies at $32.27M; Transcode Therapeutics (RNAZ) is the closest match by business profile, size, sector and industry.

    How does CNTX stock compare with its competitors?

    CNTX's net margin is 0.0% against a peer median of 0.0%.

    Which of Context Therapeutics' competitors pays a higher dividend?

    Context Therapeutics pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is Context Therapeutics bigger than its competitors?

    No. Context Therapeutics is 7th by market cap among the 13 companies on this page; the largest is Quince Therapeutics (QNCX) at $32.27M.